Pluses and minuses of the weight-loss drug bonanza
Nov 18, 2025
34:21
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Obesity treatments made by Novo Nordisk and Eli Lilly have spawned a healthcare revolution, with sales set to hit $150 bln by 2031. In this episode of The Big View, Peter Thal Larsen talks to Breakingviews Associate Editor Aimee Donnellan about their origins – and their impact.